Breadcrumbs
Rheumatology: Research Programs
Cardio-Rheumatology Network
| Research program title |
Cardio-Rheumatology Network |
|---|---|
| Program Leadership |
Dr. Lihi Eder - Co-Director Dr. Paula Harvey - Co-Director |
| Program Leadership |
Dr Dana Jerome- Division Head – Rheumatology Dr Shadi Akhtari - Division of Cardiology Dr Elsie Nguyen - Department of Medical Imaging Dr. Bindee Kuriya - Dept. of Medicine, Division of Rheumatology |
| Primary program location |
Women's College Hospital - 76 Grenville St, Toronto, ON M5G 1N8 |
| Research networks, consortia or partner institutions |
University of Toronto Mt. Sinai Hospital |
| Program website(s) |
Cardio-Rheum Network: https://www.cardiorheum.org/research WCH Cardio-Rheum: https://www.womenscollegehospital.ca/care-programs/cardiology/cardio-rheumatology-clinic/ |
| Program overview |
People with inflammatory rheumatic diseases are at elevated risk of cardiovascular disease. Nevertheless, this risk is frequently under-recognized and under-treated. The University of Toronto Cardio-Rheumatology Program, the first clinic of its kind in Canada, was established to address these gaps. The program aims to improve the prevention, early detection, and management of cardiovascular disease in patients with inflammatory rheumatic conditions. It rests on three integrated pillars. The clinical pillar focuses on the primary prevention of cardiovascular disease through a dedicated cardio-rheumatology clinic for patients with inflammatory rheumatic diseases. The research pillar, anchored by a prospective cardio-rheumatology cohort, investigates mechanisms, risk prediction, and novel preventive strategies. The education pillar includes an annual symposium for clinicians and researchers across disciplines. |
| Fellowships offered |
Contact program leaders |
| Clinical care: Does program accept new patients? |
Yes |
| Clinical referral information |
A healthcare provider referral is required. The clinic accepts patients aged 40–80 with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. Patients with pre-existing cardiovascular disease are not accepted. To refer patients to the clinic clinicians should submit the completed three-page Cardiology-Rheumatology Referral Form, including the rheumatology assessment, reason for referral, relevant medical history, current medications. Referral form: Cardiology-Rheumatology Referral Form Fax referrals to 416-323-6304 |
| Clinical studies: Does the program recruit research participants? |
Yes |
| Details of the recruiting research projects |
The cardio-rheumatology program runs two main research projects: The IMPACT study is a prospective longitudinal cohort that evaluates cardiovascular outcomes in patients with inflammatory arthritis. The study aims to optimize the management of cardiovascular co-morbidities by understanding underlying mechanisms and developing new methods for cardiovascular risk. Participants attending the cardio-rheumatology clinic have structured assessments over 5-years that include cardiovascular phenotyping including advanced imaging and laboratory biomarkers. Healthcare-provider referrals are accepted through the Cardiology-Rheumatology Referral Form; final research eligibility is confirmed by the study team. |
Gladman Krembil Psoriatic Arthritis Program
| Research program title |
Gladman Krembil Psoriatic Arthritis Program |
|---|---|
| Program Leadership |
Dr. Vinod Chandran Dr. Denis Poddubnyy Dr. Dafna Gladman, Founding Director, Professor Emerita and Scientist Emeria |
| Primary program location |
Toronto Western Hospital Schroeder Arthritis Institute, University Health Network 399 Bathurst Street Toronto, ON M5T 2S8 |
| Research networks, consortia or partner institutions |
International Psoriasis and Arthritis Research Team (IPART) Spondyloarthritis Research Consortium of Canada (SPARCC) |
| Program website(s) | |
| Program overview |
The Gladman Krembil Psoriatic Arthritis Program integrates specialized clinical care, longitudinal cohort research, translational science and education to improve early diagnosis, treatment and long-term outcomes for people with psoriasis and psoriatic arthritis. Based at Toronto Western Hospital, the program follows patients through standardized clinical assessments, laboratory testing, imaging and biospecimen collection. Research themes include disease course and prognosis; transition from psoriasis to psoriatic arthritis; genetic, proteomic, metabolomic and imaging biomarkers; treatment response and persistence; structural damage; comorbidities; and personalized care. The program conducts investigator-initiated and industry-sponsored studies and collaborates through IPART, SPARCC and international networks. Its longitudinal cohorts and biobank support clinical, translational and epidemiological research while providing training opportunities for undergraduate and graduate learners, residents and clinical fellows. |
| Fellowships offered |
Psoriatic Arthritis Fellowship - clinical and research; minimum 12 months. |
| Clinical care: Does program accept new patients? |
Yes, subject to clinical triage and program capacity. |
| Clinical referral information |
A physician referral is required for patients with suspected or established psoriatic arthritis, including possible axial involvement. Referrals may be directed to Dr. Chandran or Dr. Poddubnyy. Include the relevant rheumatologic and dermatologic history, current and previous treatments, recent laboratory and imaging results, and the reason for referral. Referrals are triaged according to clinical need. Referral fax: 416-603-5201 https://www.uhn.ca/Arthritis/Clinics/Psoriatic_Arthritis
|
| Details of the recruiting research projects |
The program prospectively recruits people with psoriasis and psoriatic arthritis into its longitudinal observational cohort. Patients with active axial involvement as part of their psoriatic arthritis may also be eligible for an interventional clinical study. Participation is subject to study-specific eligibility criteria and current recruitment availability. |
Gout and other crystalline arthropathies
| Research program title |
Gout and other crystalline arthropathies |
|---|---|
| Program Leadership |
Timothy Kwok (Associate scientist, Rheumatologist) Gregory Choy (Division head, Rheumatologist) |
| Primary program location |
Sunnybrook Health Sciences Centre
|
| Research networks, consortia or partner institutions |
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) Ontario Best Practices Research Initiative (OBRI) |
| Program website(s) | |
| Program overview |
Our research program is focused on gathering evidence using real-world and EMR data to improve the quality of care delivered to patients with gout |
| Clinical care: Does program accept new patients? |
Yes, through general rheumatology referral pathway
|
| Clinical referral information |
Fax: 416-480-4233 |
| Clinical studies: Does the program recruit research participants? |
Yes |
| Details of the recruiting research projects |
1. Development of Difficult-to-treat (D2T) gout consencus statement in collaboration with G-CAN 2. Health services research using ICES and REDI databases to assess quality of gout and crystalline arthropathy care |
Multidisciplinary Sjogren's Clinic
| Research program title |
Multidisciplinary Sjogren's Clinic |
|
|---|---|---|
| Program Leadership |
Arthur AAM Bookman MD FRCPC |
|
| Other faculty members involved |
Joan Wither MD PhD FRCPC, Rheumatology, Immunology Allan Slomovic MD FRCS, Corneal Ophthalmology John Rutka MD FRCS Neuro-Otology U of T School of Dentistry, Oral Pathology |
|
| Primary program location |
|
|
| Program website | ||
| Program overview |
Multidisciplinary evaluation of pre-screened patients with data and lab collection for clinical and bench research |
|
| Clinical Care: Does program accept new patients? |
Yes |
|
| Clinical referral information |
Referral to Sjogren’s Clinic, Rheumatology, Toronto Western Hospital Referral Fax: 416 603 5201 |
|
| Clinical studies: Does the program recruit research participants? |
Yes |
|
| Details of the recruiting research projects |
This clinic accepts patients for clinical trials in Sjogren's disease. For the most part, trials are directed at patients with extraglandular complications. Patient's for clinical trial need to assess at the multidisciplinary Sjogren's clinic to determine if they meet criteria. |
Musculoskeletal Ultrasound (MSUS) Program
| Research program title |
|
|
|---|---|---|
| Program Leadership |
Sahil Koppikar, Co-director and site lead, Women's College Hospital Samar Aboulenain, Co-director and site lead, St. Michael’s Hospital |
|
| Other faculty members involved |
Women's College Hospital • Dr. Sahil Koppikar, MD MHPE FRCPC, Rheumatology, CRUS training, MSUS fellowship (University of Toronto) • Dr. Alan Zhou, MD FRCPC, Rheumatology; CRUS, EULAR MSUS training, MSUS fellowship (University of Toronto), ACR RhMSUS™ certified St. Michael's Hospital • Dr. Samar Aboulenain, MBBCh FRCPC RhMSUS, Rheumatology; CRUS training, USSONAR, MSUS fellowship (McMaster University), ACR RhMSUS™ certified |
|
| Primary program location |
Women's College Hospital, Division of Rheumatology, 76 Grenville Street, Toronto, ON M5S 1B2 St. Michael's Hospital, Unity Health Toronto, Division of Rheumatology, 30 Bond Street, Toronto, ON M5B 1W8 |
|
| Research networks, consortia or partner institutions |
Women’s College Hospital Psoriatic Arthritis program (Dr. Lihi Eder) Mount Sinai Hospital Rheumatoid Arthritis Program (Dr. Bindee Kuriya) Canadian Rheumatology Ultrasound Society (CRUS) Ultrasound Society of North American Rheumatologists (USSONAR) |
|
| Program overview |
The Rheumatology Musculoskeletal Ultrasound (MSUS) Program is a city-wide clinical service with sites at Women's College Hospital and St. Michael's Hospital. Run by rheumatologists with formal MSK ultrasound training and certification, it integrates point-of-care ultrasound into rheumatology consultation to provide timely diagnostic clarification and image-guided procedures. The clinics serve patients with suspected or established inflammatory arthritis, crystal disease and other rheumatic conditions, assessing elementary ultrasound lesions, subclinical synovitis and enthesitis, and supporting early diagnosis of inflammatory arthritis and disease monitoring. Beyond clinical care, the program is a training platform: a one-year city-wide fellowship, clinical exposure for core rheumatology residents that complements the PGY4/5 MSK Ultrasound Curriculum, and teaching of clinical/research fellows. It also provides a platform for clinical research, quality improvement and medical education studies in MSK ultrasound. |
|
| Fellowship Offered |
Clinical full or partial fellowships for 1 year duration can be offered on case-by-case basis |
|
| Clinical Care: Does program accept new patients? |
Yes |
|
| Clinical referral information |
Scope: Ultrasound-integrated rheumatology consultation for diagnostic clarification and guided procedures, including: • Suspected or established inflammatory arthritis: synovitis, tenosynovitis, bursitis and enthesitis, including assessment for subclinical synovitis • Early diagnosis of inflammatory arthritis • Differentiating inflammatory from non-inflammatory causes of joint pain • Crystal disease (gout and CPPD) • Disease activity monitoring and sonographic assessment • Ultrasound-guided aspirations and injections Referral fax/phone: WCH (416) 323-6176; SMH (416) 864-5139 |
Myositis Program - St Michael's Hospital
| Research program title |
Myositis Program – St Michael’s Hospital |
|
|---|---|---|
| Program Leadership |
|
|
| Other faculty members involved |
Dr Charles Kassardjian – Neurology lead Angelo Papachristos – Physiotherapy/Rehab lead |
|
| Primary program location |
St. Michael's Hospital |
|
| Research networks, consortia or partner institutions |
Providence Rehab Li Ka Shing, Keenan Research Centre for Biomedical Science Women’s College Hospital/Sunnybrook, Dermatology UHN, ILD clinic University of Manchester, Myositis program University of Melbourne, Myositis program |
|
| Program website | ||
| Program overview |
Multi-disciplinary national centre of excellence for the diagnosis and management of patients with inflammatory myopathies. Areas of research focus include serological disease characterization and tissue markers, malignancy risk stratification and screening in IIM, and use of ultrasound in myopathies |
|
| Fellowship Offered |
Scheduled in 2027 – clinical and research, 1 year duration |
|
| Clinical Care: Does program accept new patients? |
Yes |
|
| Clinical referral information |
|
|
| Clinical studies: Does the program recruit research participants? |
Yes |
|
| Details of the recruiting research projects |
MyoCan Study – prospective evaluation of the 2023 IIM cancer screening guidelines Patients with new diagnosis of dermatomyositis Planned 2027: Serological and tissue markers in Dermatomyositis in collaboration with Dermatology DM Patients with active skin and muscle disease MUSIQ (Myositis Ultrasound Study of Imaging Quantification) Use of Quantitative Ultrasound in diagnosis and management of inflammatory muscle conditions Myopathy patients with new/recent diagnosis |
Pregnancy and Rheumatic Disease
| Research program title |
Pregnancy and Rheumatic Diseases |
|
|---|---|---|
| Program Leadership |
|
|
| Other faculty members involved |
Amanda Steiman MD, FRCPC. Sinai Health Dharini Mahendira MD, FRCPC, St. Michael’s Hospital Leigha Rowbottom, MD, FRCPC, Sinai Health |
|
| Primary program location |
Dr. Laskin Clinic at TRIO Fertility, 1101-655 Bay St, Toronto, ON M5G 2K4 |
|
| Research networks, consortia or partner institutions |
Partner institutions: Sinai Health, St. Michael’s Hospital, Sunnybrook Health Sciences |
|
| Program overview |
Learning to evaluate and manage patients with underlying rheumatic diseases. Daily clinical experience with all participating clinics. Rotations in high risk pregnancy clinics; obstetric medicine; obstetric hematology; renal and pregnancy clinic. Monthly case presentations/rounds. Research projects directed to pregnancy issues in rheumatic diseases. Collaborations through the recently created national network Reproduction in Rheumatic Diseases. This fellowship is the only fellowship specifically directed to pregnancy and rheumatic diseases in Canada |
|
| Fellowship Offered |
Pregnancy and Rheumatic Diseases. Clinical fellowship with research opportunities. This is a one-year fellowship. Funding through Lupus Ontario is only available to those trainees planning to practice in Ontario or Canada. |
|
| Clinical Care: Does program accept new patients? |
Yes |
|
| Clinical referral information |
Referrals from rheumatologists, other medical specialties, obstetricians of patients either pregnant or planning a pregnancy. The pre-pregnancy assessment is stressed to determine the safety of the woman undertaking a pregnancy. Referrals are faxed to: 416-599-8624. |
|
| Clinical studies: Does the program recruit research participants? |
Yes |
|
| Details of the recruiting research projects |
Research projects are undertaken as per the faculty recommendations including the current fellow. |
Psoriatic Arthritis Research Program at Women's College Hospital
| Research program title |
Psoriatic Arthritis Research Program at Women’s College Hospital |
|
|---|---|---|
| Program Leadership |
Lihi Eder, Program Director |
|
| Other faculty members involved |
Sahil Koppikar, Rheumatologist & Assistant Professor of Medicine at the University of Toronto |
|
| Primary program location |
Women’s College Hospital 76 Grenville Street, Toronto, ON M5S1B2 |
|
| Research networks, consortia or partner institutions |
|
|
| Program website(s) |
|
|
| Program overview |
The Psoriatic Arthritis Research Program at Women’s College Research Institute, aims to improve outcomes for people living with psoriatic arthritis (PsA) through earlier diagnosis, equitable care, and prevention of long-term disability. The program serves individuals with psoriasis and PsA, integrating a specialty clinic with standardized collection of clinical, imaging, and biological data to support research and patient care. Its major research themes include early detection and risk prediction of PsA, sex- and gender-based differences in disease outcomes, musculoskeletal ultrasound for diagnosis and monitoring, and cardio-metabolic comorbidities, including obesity care in psoriatic disease. The program employs clinical epidemiology, imaging, longitudinal cohort studies, and translational research methods. Distinctive strengths include its internationally recognized expertise in musculoskeletal ultrasound, interdisciplinary collaboration with dermatology and cardiology, and participation in major networks such as GRAPPA and IPART, which provide access to large, richly characterized patient cohorts. |
|
| Fellowship offered |
Musculoskeletal Ultrasound and Psoriatic Arthritis Fellowship: clinical research fellowship, 1-2 years duration. |
|
| Clinical care: Does program accept new patients | Yes | |
| Clinical referral information |
Completed referral form to be faxed to 416 323 6176 https://www.womenscollegehospital.ca/care-programs/psoriatic-arthritis-psa-service/ |
|
| Clinical studies: Does the program recruit research participants? |
Yes |
|
| Details of the recruiting research projects |
We accept referrals to studies for patient with diagnosed psoriatic arthritis (PsA), or patients with psoriasis with suspected PsA |
Real-World Evidence & Health System Innovation in Musculoskeletal Care
| Research program title |
Real-World Evidence & Health System Innovation in Musculoskeletal Care |
|
|---|---|---|
| Program Leadership |
Jessica Widdifield PhD
|
|
| Other faculty members involved |
Research collaborations span a diverse group of adult and pediatric rheumatologists within the Division of Rheumatology. |
|
| Primary program location |
ICES and Sunnybrook Research Institute, Toronto |
|
| Research networks, consortia or partner institutions |
Principal Investigator:
Principal Investigator / Senior Methodological Expert:
|
|
| Program website |
|
|
| Program overview |
This research program bridges population health research and implementation science to improve the delivery, quality, and outcomes of care for people living with rheumatic and musculoskeletal diseases (RMDs) across the care continuum. Drawing on real-world, population-based health administrative data and electronic medical records (EMRs) alongside advanced epidemiological and health services research methods, the program generates evidence on disease burden, health outcomes, quality of care, health care utilization, and effectiveness of treatment and models of care. Quantitative analyses are complemented by mixed-methods approaches (surveys, interviews), evidence syntheses, and implementation science to understand gaps in care and identify solutions for improvement to inform clinical care, health system design, and health policy at local, national, and international levels. The overarching goal is to generate real-world evidence that informs clinical practice, strengthens health system sustainability and optimizes outcomes for individuals living with RMDs. Research is structured around four primary pillars:
|
|
| Fellowship Offered |
Yes – research (graduate and postdoc positions) |
Rheumatoid Arthritis (RA) Clinical and Research Program
| Research program title |
|
||
|---|---|---|---|
| Program Leadership |
Dr. Bindee Kuriya, MD, SM, FRCPC — Principal Investigator, Ontario Best Practices Research Initiative (OBRI); Associate Professor and Clinician-Investigator, Division of Rheumatology, Department of Medicine, University of Toronto |
||
| Other faculty members involved |
Dr. Sahil Koppikar; Dr. Alexandra Saltman; Dr. Megan Himmel — collaborating faculty and co-fellowship directors supporting advanced clinical training in RA, immuno-oncology and musculoskeletal ultrasound. |
||
| Primary program location |
Mount Sinai Hospital, Sinai Health System, Rebecca MacDonald Centre for Arthritis and Autoimmune Disease 60 Murray Street, Room 2-008, Toronto, Ontario M5T 3L9, Canada. |
||
| Research networks, consortia or partner institutions |
Ontario Best Practices Research Initiative (OBRI), an Ontario-wide, longitudinal, real-world RA registry (PI: Dr. Kuriya), integrated within the Schroeder Arthritis Institute / University Health Network research environment; Site Investigator for the Canadian Early Arthritis Cohort (CATCH), a national early-RA cohort; collaborations with ICES for population-based health-data linkage, Medical Advisory for the Canadian Arthritis Patient Alliance (CAPA) |
||
| Program website |
Sinai Health Rheumatology: https://www.sinaihealth.ca/areas-of-care/rheumatology Dedicated RA program / fellowship webpages: Rheumatoid Arthritis & Immune-Oncology | Department of Medicine |
||
| Program overview |
The RA Clinical and Research Program at Mount Sinai Hospital integrates specialized referral care, real-world evidence, clinical trials and advanced fellowship training to improve outcomes for adults with rheumatoid arthritis. Dr. Bindee Kuriya provides expert assessment and longitudinal management of complex and difficult-to-treat RA, accepting referrals from across Ontario. As Principal Investigator of the Ontario Best Practices Research Initiative (OBRI), Canada’s largest provincial real-world RA registry, she leads studies of treatment effectiveness, disease trajectories, multimorbidity, patient-reported outcomes and healthcare utilization. Her research also draws on the Canadian Early Arthritis Cohort (CATCH), linked administrative health data and collaborative clinical cohorts. At Mount Sinai Hospital, she contributes to industry-sponsored therapeutic trials and leads investigator-initiated pragmatic studies, including trials of practical strategies for managing RA flares. The program translates research into routine care while training the next generation of RA specialists. |
||
| Fellowship Offered |
• RA / Immuno-Oncology Fellowship — advanced clinical fellowship emphasizing RA diagnosis, management and complex cases, with exposure to rheumatic complications of cancer immunotherapy; co-directed with collaborating faculty. Type: Clinical. Duration: 1-2 years • RA and Musculoskeletal (MSK) Ultrasound Fellowship — advanced training in RA diagnosis and treatment, ultrasound assessment and procedural skills, with opportunities for clinical research and observational or trial-based scholarship. Type: Clinical and research. Duration: 1-2 years |
||
| Clinical care: Does the program accept new patients? |
|
||
| Clinical referral information |
Adult patients (age ≥18 years) may be referred for suspected or established RA, particularly difficult-to-treat RA, persistent disease activity despite advanced therapies, diagnostic uncertainty or complex treatment decisions. Selected other inflammatory arthritis referrals are accepted as described above. Please include the reason for referral, pertinent clinical notes, prior and current DMARD / biologic / targeted-therapy history, relevant laboratory results and imaging / X-ray reports. Referral route: Ocean eReferral or fax to 416-284-4997 |
||
| Clinical studies: Does the program recruit research participants? |
Yes. The program recruits or participates in longitudinal observational studies, RA clinical cohorts, investigator-initiated pragmatic randomized trials and therapeutic trials conducted through Mount Sinai Hospital. Research spans early RA through established and treatment-refractory disease. Recruitment depends on the eligibility criteria and enrollment status of each individual study; being referred to the clinical program does not guarantee participation in a trial. |
||
| Details of the recruiting research projects |
OBRI real-world RA registry: adults with physician-diagnosed RA receiving routine care at participating Ontario rheumatology practices; longitudinal study of treatment patterns, effectiveness, disease outcomes, comorbidities, patient-reported outcomes and healthcare utilization. Enrollment / referrals through participating sites, subject to current recruitment status. • CATCH early-arthritis cohort: people with recent-onset inflammatory arthritis / early RA recruited through participating Canadian study centres; focuses on early disease, treatment and long-term outcomes. Referral and enrollment arrangements depend on participating sites. • STORM-RA pragmatic trial: adults with RA experiencing a flare who meet protocol criteria; compares intramuscular methylprednisolone with a short oral prednisone taper in routine clinical practice, with measures of flare impact, response, safety and patient experience. Conducted collaboratively through Sinai and McMaster; recruitment status and referral pathway to be confirmed. • Mount Sinai therapeutic RA trials: adults with RA, from treatment-naïve to treatment-refractory, potentially eligible for investigational or established advanced therapies under protocol-specific criteria. Study availability and external referrals are assessed individually. • Other linked clinical / observational projects: RA multimorbidity and cardiovascular risk, medication effectiveness and safety, care delivery, and immuno-oncology-associated rheumatic disease research, according to protocol-specific eligibility. Contact the research team through the clinical service to ask about active opportunities. |
Spondyloarthritis (Spondylitis) Program
| Research program title |
|
|
|---|---|---|
| Program Leadership |
Dr. Robert D. Inman, Co-Director |
|
| Other faculty members involved |
Laura Passalent, Extended Scope Physiotherapist |
|
| Primary program location |
Toronto Western Hospital |
|
| Research networks, consortia or partner institutions | Assessment of SpondyloArthritis international Society (ASAS) Spondyloarthritis Research and Treatment Network (SPARTAN) |
|
| Program website(s) | Axial Spondyloarthritis Clinic Spondylitis Screening Clinic |
|
| Program overview |
The Spondyloarthritis Program integrates specialized clinical care, early-detection pathways, longitudinal research and education for people with axial spondyloarthritis. Based at Toronto Western Hospital, the program includes a dedicated clinic for patients with established disease and the Spondylitis Screening Clinic, which provides comprehensive assessment of adults with chronic back pain beginning before age 45. In the screening pathway, extended-scope practitioners with specialized training assess patients in close collaboration with rheumatologists; patients with findings suggestive of axial spondyloarthritis are referred for rheumatology consultation and diagnostic confirmation. |
|
| Fellowship Offered |
Clinical and research fellowship in spondyloarthritis; duration 1–2 years. View fellowship description |
|
| Clinical Care: Does program accept new patients? |
Yes, subject to clinical triage, eligibility for the relevant clinic and program capacity. |
|
| Clinical referral information |
A physician referral is required. The dedicated screening clinic assesses adults with back pain lasting more than three months that began before age 45. Patients with established or suspected axial spondyloarthritis may be directed to the appropriate program clinic. Referrals are triaged according to clinical need and clinic eligibility. Axial Spondyloarthritis Clinic | Spondylitis Screening Clinic |
|
| Clinical studies: Does the program recruit research participants? |
Research participation may be available through longitudinal observational studies and other program studies, subject to study-specific eligibility criteria and current recruitment availability. |
|
| Details of the recruiting research projects |
Potential participants are assessed for relevant longitudinal cohort studies and other active research projects within the program. Availability and eligibility should be confirmed directly with the program. |
Toronto Clinical Osteoarthritis Research Program
| Research program title |
Toronto Clinical Osteoarthritis Research Program |
|
|---|---|---|
| Program Leadership |
|
|
| Primary program location |
St. Michael’s Hospital, Toronto Women’s College Hospital, Toronto |
|
| Program overview |
The Toronto Clinical Osteoarthritis Research Program focuses on improving the recognition, treatment, and outcomes of osteoarthritis. This includes identifying osteoarthritis at an early stage, understanding its impact on health and functional independence, identifying and addressing disparities in access to and outcomes of care, and evaluating new treatments. Our research program brings together patients, clinicians, and researchers, including international collaborations, to address priorities that matter to people living with arthritis. |
|
| Fellowship Offered |
Graduate students and postdoctoral fellows. |
|
| Clinical Care: Does program accept new patients? |
The Rheumatology Osteoarthritis Clinic at St. Michael’s Hospital provides specialized assessment and care for people with suspected or confirmed osteoarthritis. The clinic is linked to our clinical research program, and patients may be invited to participate in relevant studies. |
|
| Clinical referral information |
Referrals can be sent to Dr. Lauren King, Rheumatology, St. Michael’s Hospital. Tel: 416-864-5420 Fax: 416-864-5139 |
|
| Clinical studies: Does the program recruit research participants? |
Yes |
|
| Details of the recruiting research projects |
Cohort studies and clinical trials |
Toronto Lupus Program
| Research program title |
Toronto Lupus Program |
|---|---|
| Program Leadership |
Dr. Zahi Touma, MD, PhD Program Director Associate Professor of Medicine| University of Toronto Scientist| Schroeder Arthritis Institute |
| Other faculty members involved |
Dr. Laura Whittall-Garcia, MD, MSc Assistant Professor of Medicine | University of Toronto Clinician Investigator | Schroeder Arthritis Institute Dr. Dafna Gladman, MD Professor Emeritus | University of Toronto Emeritus Scientist| Schroeder Arthritis Institute Dr. Joan Wither, MD, PhD Professor of Medicine and Immunology | University of Toronto Senior Scientist Schroeder Arthritis Institute |
| Primary program location |
Toronto Lupus Program Toronto Western Hospital| Rheumatology Department 399 Bathurst Street Toronto, Ontario M5T 2S8
|
| Research networks, consortia or partner institutions |
|
| Program website | |
| Program overview |
The Toronto Lupus Program is an internationally recognized academic lupus centre based at Toronto Western Hospital, University Health Network. Serving a large and diverse population of patients with systemic lupus erythematosus, the program integrates specialized clinical care with a robust research infrastructure built around one of the world's most established longitudinal lupus cohorts. Research spans observational cohort studies, biomarker discovery, neuroimaging, lupus nephritis, neuropsychiatric lupus, clinical epidemiology, and clinical trials. Patients benefit from coordinated care across rheumatology, nephrology, dermatology, and antiphospholipid and adult transition clinics, while investigators leverage extensive longitudinal clinical and biospecimen data to advance personalized approaches to lupus management. Strong partnerships with the University of Toronto, the Krembil Research Institute, and international collaborators position the program as a global leader in lupus research, training, and innovation. |
| Fellowship Offered |
Systemic Lupus Erythematosus Fellowship https://deptmedicine.utoronto.ca/systemic-lupus-erythematosus |
| Clinical Care: Does program accept new patients? |
Yes |
| Clinical referral information |
Patients with a confirmed or suspected diagnosis of systemic lupus erythematosus (SLE) may be referred to the Lupus Clinic at Toronto Western Hospital, for specialized assessment and management. The clinic provides care for individuals with lupus and related complications.
Referral webpage: https://www.uhn.ca/Arthritis/Clinics/Lupus_Clinic |
| Clinical studies: Does the program recruit research participants? |
Yes |
| Details of the recruiting research projects |
Clinical trials recruiting for adults with SLE to evaluate emerging new therapies and novel treatment strategies. Eligibility varies by study but generally includes patients with confirmed SLE. |
Vasculitis
| Research program title |
Vasculitis |
|---|---|
| Program Leadership |
Drs. Christian Pagnoux and Medha Soowamber
|
| Primary program location |
Mount Sinai Hospital Vasculitis clinic, Division of Rheumatology Department of Medicine, University of Toronto 60, Murray street Rooms 2-220/221/222/226 BOX 8 Toronto, ON, M5T 3L9
|
| Research networks, consortia or partner institutions |
CanVasc (Canadian Vasculitis research network; Founding member) VCRC (Vasculitis Clinical Research Consortium; Steering committee member)
|
| Program website(s) |
canvasc.ca |
| Program overview |
The vasculitis program aims at delivering a comprehensive clinical, educational, and/or clinical research experience in vasculitis. The center is one of the largest in North America to manage patients with all types of vasculitis, as well as a leading teaching and clinical research center in Canada. |
| Fellowship Offered |
Vasculitis fellowship (clinical, with possibilities of added clinical research projects). Duration of 6 months to 2 years maximum (ideally/preferred: 1 year). Candidates need to secure (at least partially) the funding to support their fellowship, from the originating university/division/province/country. |
| Clinical Care: Does program accept new patients? |
Yes
|
| Clinical referral information |
Medical referrals for patients with vasculitis (or suspected vasculitis) should be sent through fax or through Ocean referral platform. General fax 416 586 4800 x8766 (To : Vasculitis clinic) GCA fast track clinic (Dr Soowamber): form to completed https://www.sinaihealth.ca/media/20661/download?inline Fax to: 647-427-2120 |
| Clinical studies: Does the program recruit research participants? |
Yes, for specific clinical research studies in vasculitis |
| Details of the recruiting research projects |
The list of studies in vasculitis potentially recruiting participants in Canada is on the CanVasc.ca website (study protocol page). |